Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus: Difference between revisions
No edit summary |
Esther Lee (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Unstable angina / NSTEMI}} | {{Unstable angina / NSTEMI}} | ||
{{CMG}}; '''Associate Editors-in-Chief:''' [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S. | {{CMG}}; '''Associate Editors-in-Chief:''' [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S. | ||
==ACC / AHA Guidelines for Diabetes Mellitus<ref name="pmid22800849">{{cite journal| author=2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR et al.| title=2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2012 | volume= 126 | issue= 7 | pages= 875-910 | pmid=22800849 | doi=10.1161/CIR.0b013e318256f1e0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22800849 }} </ref>== | |||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"| | |||
[[ACC/AHA guidelines classification scheme#Classification of Recommendations|ClassI]] | |||
|- | |||
| bgcolor="LightGreen"| | |||
<nowiki>"</nowiki>'''1.''' Medical treatment in the acute phase of [[UA/NSTEMI]] and decisions on whether to perform stress testing, [[angiography]], and [[revascularization]] should be similar in patients with and without [[diabetes mellitus]].55,72,81,147 ([[ACC AHA guidelines classification scheme#Level of Evidence|Level A]])<nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| | |||
[[ACC/AHA guidelines classification scheme#Classification of Recommendations|ClassIIa]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' For patients with [[UA/NSTEMI]] and multivessel disease, [[CABG]] with use of the internal mammary arteries can be beneficial over [[PCI]] in patients being treated for [[diabetes mellitus]].148 ([[ACC/AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' [[PCI]] is reasonable for [[UA/NSTEMI]] patients with [[diabetes mellitus]] with single-vessel disease and [[inducible ischemia]].55 ([[ACC/AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.''' It is reasonable to use an [[insulin]]-based regimen to achieve and maintain glucose levels less than 180 mg/dL while avoiding [[ hypoglycemia]]* for hospitalized patients with [[UA/NSTEMI]] with either a complicated or uncomplicated course.149–152 ([[ACC/AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | |||
|} | |||
==See Also== | ==See Also== |
Revision as of 15:26, 9 October 2012
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
ACC / AHA Guidelines for Diabetes Mellitus[1]
"1. Medical treatment in the acute phase of UA/NSTEMI and decisions on whether to perform stress testing, angiography, and revascularization should be similar in patients with and without diabetes mellitus.55,72,81,147 (Level A)" |
"1. For patients with UA/NSTEMI and multivessel disease, CABG with use of the internal mammary arteries can be beneficial over PCI in patients being treated for diabetes mellitus.148 (Level B)" |
"2. PCI is reasonable for UA/NSTEMI patients with diabetes mellitus with single-vessel disease and inducible ischemia.55 (Level B)" |
"3. It is reasonable to use an insulin-based regimen to achieve and maintain glucose levels less than 180 mg/dL while avoiding hypoglycemia* for hospitalized patients with UA/NSTEMI with either a complicated or uncomplicated course.149–152 (Level B)" |
See Also
References
- ↑ 2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR; et al. (2012). "2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 126 (7): 875–910. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849.